The New York Times | Our Drug Supply Is Sick. How Can We Fix It?
The New York Times released an article titled "Our Drug Supply Is Sick. How Can We Fix It?" Farah Stockman discusses how the American healthcare system is built upon the widely disputed concept that generic drugs are considered equal to one another and the name brand. The piece recognizes Valisure as a leader attempting to address these issues and highlights the opportunities for change through action by large health systems.
View the full article via The New York Times here.
